Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|
April 1, 1982
[Immune system characteristics in acute pneumonia]
A V Bykova, N M Ivanova, O I Korol'
Bulletin of Experimental Biology and Medicine
|
March 16, 2021
Effect of Ester Derivative of Indomethacin on Immune Inflammation
A V Bykova, V V Bykov, S A Stankevich, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]
|
November 24, 1998
[Efficacy of lomefloxacin in treatment of patients with chronic bronchitis]
G B Fedoseev, A V Emel'ianov, K A Rudinskiĭ, et al.
Bulletin of Experimental Biology and Medicine
|
September 28, 2023
Pharmacological Effects of a New Indolinone Derivative in Experimental Pneumonitis in Rats
V V Bykov, V S Motov, A V Bykova, et al.
Bulletin of Experimental Biology and Medicine
|
February 1, 2023
Anti-Atherosclerotic Action of a New Stimulator of Soluble Guanylate Cyclase in an Experiment
V V Bykov, A V Bykova, A N Dzyuman, et al.
Terapevticheskii Arkhiv
|
October 26, 2022
[Withdrawal syndrome after tyrosine kinase inhibitors discontinuation in patients with chronic myeloid leukemia]
E Y Chelysheva, A N Petrova, O A Shukhov, et al.
Bulletin of Experimental Biology and Medicine
|
May 9, 2024
Analgesic and Psychotropic Effects of a New Bradykinin Antagonist
A E Aliforenko, V S Motov, V V Bykov, et al.
Bulletin of Experimental Biology and Medicine
|
September 11, 2019
Multipotent Mesenchymal Stromal Cells in Patients with Chronic Myeloid Leukemia before Discontinuation of Tyrosine Kinase Inhibitors
N A Petinati, A N Petrova, E Yu Chelysheva, et al.
Bulletin of Experimental Biology and Medicine
|
November 17, 2023
Pharmacological Effects of a New Soluble Guanylate Cyclase Stimulator in Experimental Ischemic Stroke
V V Bykov, A V Bykova, V S Motov, et al.
Terapevticheskii Arkhiv
|
February 8, 2018
[Results of following up patients with chronic myeloid leukemia and a deep molecular response without tyrosine kinase inhibitor therapy]
A G Turkina, E Yu Chelysheva, V A Shuvaev, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|
April 1, 1982
[Immune system characteristics in acute pneumonia]
A V Bykova, N M Ivanova, O I Korol'
Bulletin of Experimental Biology and Medicine
|
March 16, 2021
Effect of Ester Derivative of Indomethacin on Immune Inflammation
A V Bykova, V V Bykov, S A Stankevich, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]
|
November 24, 1998
[Efficacy of lomefloxacin in treatment of patients with chronic bronchitis]
G B Fedoseev, A V Emel'ianov, K A Rudinskiĭ, et al.
Bulletin of Experimental Biology and Medicine
|
September 28, 2023
Pharmacological Effects of a New Indolinone Derivative in Experimental Pneumonitis in Rats
V V Bykov, V S Motov, A V Bykova, et al.
Bulletin of Experimental Biology and Medicine
|
February 1, 2023
Anti-Atherosclerotic Action of a New Stimulator of Soluble Guanylate Cyclase in an Experiment
V V Bykov, A V Bykova, A N Dzyuman, et al.
Terapevticheskii Arkhiv
|
October 26, 2022
[Withdrawal syndrome after tyrosine kinase inhibitors discontinuation in patients with chronic myeloid leukemia]
E Y Chelysheva, A N Petrova, O A Shukhov, et al.
Bulletin of Experimental Biology and Medicine
|
May 9, 2024
Analgesic and Psychotropic Effects of a New Bradykinin Antagonist
A E Aliforenko, V S Motov, V V Bykov, et al.
Bulletin of Experimental Biology and Medicine
|
September 11, 2019
Multipotent Mesenchymal Stromal Cells in Patients with Chronic Myeloid Leukemia before Discontinuation of Tyrosine Kinase Inhibitors
N A Petinati, A N Petrova, E Yu Chelysheva, et al.
Bulletin of Experimental Biology and Medicine
|
November 17, 2023
Pharmacological Effects of a New Soluble Guanylate Cyclase Stimulator in Experimental Ischemic Stroke
V V Bykov, A V Bykova, V S Motov, et al.
Terapevticheskii Arkhiv
|
February 8, 2018
[Results of following up patients with chronic myeloid leukemia and a deep molecular response without tyrosine kinase inhibitor therapy]
A G Turkina, E Yu Chelysheva, V A Shuvaev, et al.
Page
of 1